PBHPrestige Consumer Healthcare Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−14% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −14% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PBH is trading
Prestige Consumer Healthcare Inc. is −24% over the past year while the S&P 500 is +18%: 42 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −14%
vs 200-day average · a clear downtrend
- RSI (14)
- 57
RSI (14) · neutral
- Below its 52-week high
- 31%
Below its 52-week high
Details›
- Last close2026-10-09
- $48.25
- 1 monthS&P 500 +2.7%
- +2.0%
- 1 yearS&P 500 +18%
- −24%
- 5 yearsS&P 500 +88%
- −9.8%
- vs 50-day average$49.56
- −2.6%
- 52-week high
- $70.21
- 52-week low
- $44.76
- Annualised volatility
- 30%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$66K
| Year | Return |
|---|---|
| 2026 (year to date) | −22% |
| 2025 | −21% |
| 2024 | +28% |
| 2023 | −2.2% |
| 2022 | +3.2% |
| 2021 | +74% |
| 2020 | −14% |
| 2019 | +31% |
| 2018 | −30% |
| 2017 | −15% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +0.22% |
| Feb | 10 | 7 of 10 | +1.7% |
| Mar | 10 | 5 of 10 | −1.2% |
| Apr | 10 | 3 of 10 | −1.1% |
| May | 10 | 5 of 10 | −0.72% |
| Jun | 10 | 7 of 10 | +3.1% |
| Jul | 11 | 7 of 11 | +1.6% |
| Aug | 11 | 4 of 11 | −3.4% |
| Sep | 11 | 2 of 11 | −2.0% |
| Oct | 11 | 6 of 11 | +0.03% |
| Nov | 10 | 6 of 10 | +3.9% |
| Dec | 10 | 6 of 10 | +0.53% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #11 of 41 by RyuScore